The abstract is read at the publisher; the summary is JClub's.
Inducible N-MYC expression in mouse BCC models promotes an NICD low;K10 low;Ki67+ undifferentiated, transit-amplifying progenitor-like state, and N-Myc ablation blunts tumor formation.
- Why it matters: While Hedgehog-activating driver mutations initiate BCC, how recurrent secondary changes shape early tumor cell states and progression remains unclear.
- What they did: The team used spatial transcriptomics on nascent murine BCC-like tumors to identify two marker-defined subpopulations, then created mouse BCC cell lines under “RRi conditions” and tested inducible N-Myc and its genetic ablation in mice.
- The result: Imiquimod regresses nascent lesions and destabilizes N-MYC protein in a GSK3- and proteasome-dependent manner, supporting N-MYC as a target to restrict progression.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.